UnitedHealth stock rises on short-term momentum but faces resistance as overbought signals warn of pullback

UnitedHealth shares are trading at $317.97, up $13.41 (4.13%) over the past week, positioning the stock above its MA-20 ($306.95) and MA-50 ($312.79). This move signals strengthening medium-term momentum. Yet the stock remains well below its MA-200 at $465.66, underscoring persistent long-term downward pressure. Despite the recent advance, technical indicators reveal a fragile foundation. The weekly MACD is bearish, and ADX readings show weak overall trend strength — gains have not been accompanied by conviction. Instead, Stochastic RSI, CCI, and Bull/Bear Power all reflect overbought conditions, suggesting buyer dominance has stretched momentum thin. The nearest dynamic support sits at $312.79, with firm weekly support at $307. Resistance looms at $325. With a 25% probability of continued upward movement, the odds favor neither breakout nor collapse. A retreat toward $307–$310 is plausible if profit-taking accelerates. The baseline scenario is consolidation within the $307–$325 range over the next five trading days, as the market absorbs recent gains and awaits new directional catalysts.